Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out a bid to reduce costs as it faces tougher competition for dry eye treatment Restasis, its second-biggest product after Botox.

Amgen and Novartis migraine drug hits the mark again

Amgen and Novartis migraine drug hits the mark again and repurposed medicines such as the anticonvulsant topiramate or Allergan's Botox.

Race to CGRP migraine drug finish line enters the final straight

Race to CGRP migraine drug finish line enters the final straight medicines such as the anticonvulsant topiramate or Allergan's Botox.

Allergan pushes on with Botox for depression

Allergan pushes on with Botox for depression The specialty pharma group took the decision to test Botox in depression after external research groups showed evidence of efficacy in MDD in two separate early-stage trials. ... But analyst Ronny Gal of Bernstein thinks that if the gamble pays off, a

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal Saunders said the deal gives its aesthetic pharmaceuticals business another pillar alongside Botox for facial wrinkles, its plastic surgery products and regenerative medicines. ... The division grew 40% to $1.62bn last year, with the sales increase

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics